The current Editorial team will attempt to build further on this success. The Journal will remain the forum for publication of new scientific discoveries, novel clinical observations, evidence based changes in treatment paradigms or any other advancements in the understanding of liver pathobiology and disease. If an author has great scientific, technical or clinical observations they want to publish, they should think of the Journal of Hepatology first. We will continue to ensure that the process of submission is easy and the peer-review process fair, rapid, and transparent. If you have a great idea for a review, we encourage you to contact us to see whether this is suitable for the Journal. As the number of submissions to the Journal increases, unfortunately, many excellent papers will not find a place in the Journal. We are all aware of the enormous amount of time one spends preparing a paper for submission and then to receive an early rejection seems very unfair. In order to make the submission process easy and quick, we are therefore introducing a relatively painless submission process; 'Your paper, Your way', which means that within reason, we will review your paper without special requirements concerning formatting of the article, references, figures, and tables, as long as the scientific content of the paper can be evaluated. The new guidelines for authors will describe these basic requirements.
We also recognize the need in a small number of cases for a 'Fast-Track Review' and rapid publication, which we will introduce. This will be suitable for 'breakthrough' observations, high impact clinical trials, and some exceptional scientific discoveries. A pathway for such a Fast-Track Review is being introduced.
The large number of papers submitted from Asia is a reflection of the burden of disease and increasing scientific enterprise in these geographical areas. Despite the large number of papers submitted from Asia the acceptance rates are still relatively low. But it is clear that the rates of acceptance are starting to increase and no doubt, in the recent future, Asia will catch up with the West. The Journal of Hepatology sees itself as a global journal tackling a global problem. Understanding the differences in disease characteristics and the influence of genetic, dietary, environmental, and socio-political factors on the manifestations of liver diseases and their treatment can provide a new understanding. In order to make the contents of the Journal available to a larger audience, we have launched a Chinese and a Russian translation of the Journal. Furthermore, we are working on a proposal to start a section that will focus on 'Global issues in Hepatology'.
Governance in publication is a rapidly emerging important issue, which the new team is taking seriously. In response to the need, Professor Richard Moreau, who was an Editor with the previous Editorial team will act as a Senior Editor, looking at governance issues in relation to the Journal. Plagiarism and unethical practices in science and publication are a sad but real problem. Although, rebuttals regarding decisions made by the Editorial Board are strongly discouraged, there will be occasional cases where genuine mistakes have been made, and in a small number of cases the Senior Editor will step in to review the decision making process. Conflicts of interest are an inevitable part of life for an academic researcher or a clinician and Professor Moreau will ensure, that when these are present, they are fully declared and adequate provisions are made to guarantee that the authors get a fair peer-review.
I will be helped in running the Journal by Professor Jessica Zucmann-Rossi, Professor Thomas Berg and Professor Ramon Bataller, who are well-known experts in their own field, and will in most instances be responsible for papers dealing with basic science and cancer; viral hepatitis; and alcoholic and non-alcoholic fatty liver disease, respectively. They bring a huge amount of energy, expertise, scientific brilliance, and imagination, which I hope indicates to the submitting authors that we are ready to engage with high-quality basic science, while maintaining a very strong clinical focus and a full dedication to editorial excellence. Fig. 1 describes the complete list of the Associate Editors, Special Section Editors, and the Editorial team, who are all leaders in their chosen field. The Journal office is based in Geneva, co-located within the EASL office. Joel Walicki leads an amazing team supported by Ursula Loizides, (Editorial Coordinator) and Sophie Jarlier (Graphic designer). Sybrand Boer Iwema from Elsevier will provide us with the publishing support.
There will be few changes in the format of the articles with the modification/introduction of new sections. These are briefly described below:
1. Original Articles. We recognize that although over 90% of scientific articles fit into a standard format available in the Journal, about 10% do not. Taking this into account, we are introducing four additional types of Original Articles: a. Theory Articles: These articles will describe modelling studies, which are mainly theoretical. b. Resource Articles: These articles will describe technical advances in science or in the practice of Hepatology. c. Matters arising Articles: These articles will be specially formatted to allow publication of papers that directly contradict a previously published paper in the Journal of Hepatology. d. Brief Communications: They will be very high impact articles that concisely describe highly novel and innovative findings.
